1.43 - 1.45
1.18 - 2.36
880.0K / 1.73M (Avg.)
-18.00 | -0.08
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-184.58%
Negative net income growth while 1113.HK stands at 49.24%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
22.41%
Some D&A expansion while 1113.HK is negative at -72.68%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
118.34%
Deferred tax of 118.34% while 1113.HK is zero at 0.00%. Bruce Berkowitz would see a partial difference that can matter for future cash flow if large in magnitude.
-37.25%
Negative yoy SBC while 1113.HK is 0.00%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
183.98%
Working capital change of 183.98% while 1113.HK is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might affect near-term cash flow.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
165.56%
Growth of 165.56% while 1113.HK is zero at 0.00%. Bruce Berkowitz would see a difference in minor WC usage that might affect short-term cash flow if large.
45.40%
Lower 'other non-cash' growth vs. 1113.HK's 269.31%, indicating steadier reported figures. David Dodd would confirm no missed necessary write-downs or gains.
262.25%
Operating cash flow growth below 50% of 1113.HK's 1111.89%. Michael Burry would see a serious shortfall in day-to-day cash profitability.
-18.25%
Negative yoy CapEx while 1113.HK is 0.00%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
-9977.55%
Negative yoy acquisition while 1113.HK stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
-73.66%
Both yoy lines negative, with 1113.HK at -110.28%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
159.35%
Liquidation growth of 159.35% while 1113.HK is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
-200.00%
We reduce yoy other investing while 1113.HK is 200.00%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-157.29%
Both yoy lines negative, with 1113.HK at -135.89%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
100.00%
Debt repayment 1.25-1.5x 1113.HK's 78.63%. Bruce Berkowitz would see an edge in lowering interest burdens unless competitor invests in profitable expansions.
-86.46%
Negative yoy issuance while 1113.HK is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
No Data
No Data available this quarter, please select a different quarter.